Yulong Wang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 11, 2026

Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer.

Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer.

Journal: Cell reports. Medicine
Published: August 04, 2025

Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.

Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.

Journal: Nature communications
Published: June 07, 2023

Integrated proteogenomic characterization of medullary thyroid carcinoma.

Integrated proteogenomic characterization of medullary thyroid carcinoma.

Journal: Cell discovery
Published: April 23, 2022

Radiogenomic Analysis of Papillary Thyroid Carcinoma for Prediction of Cervical Lymph Node Metastasis: A Preliminary Study.

Radiogenomic Analysis of Papillary Thyroid Carcinoma for Prediction of Cervical Lymph Node Metastasis: A Preliminary Study.

Journal: Frontiers in oncology
Published: March 19, 2021

Author Correction: ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.

Author Correction: ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.

Journal: Nature cell biology
Published: February 03, 2021

Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.

Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer.

Journal: The Journal of clinical endocrinology and metabolism
Published: December 12, 2018

Surgical Confirmation of Incomplete Treatment for Primary Papillary Thyroid Carcinoma by Percutaneous Thermal Ablation: A Retrospective Case Review and Literature Review.

Surgical Confirmation of Incomplete Treatment for Primary Papillary Thyroid Carcinoma by Percutaneous Thermal Ablation: A Retrospective Case Review and Literature Review.

Journal: Thyroid : official journal of the American Thyroid Association
Published: July 03, 2018

Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC.

Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC.

Journal: International journal of endocrinology
Published: December 18, 2017

ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.

ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functions.

Journal: Nature cell biology
Published: October 24, 2017

DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer.

DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer.

Journal: OncoTargets and therapy
Published: May 05, 2016

Association between rs12045440 Polymorphism in the CAPZB Intron and Serum TSH Concentrations in Chinese Thyroid Tumor Patients.

Association between rs12045440 Polymorphism in the CAPZB Intron and Serum TSH Concentrations in Chinese Thyroid Tumor Patients.

Journal: International journal of endocrinology
Published: April 18, 2015
Showing 1-12 of 12

Last Updated: 09/26/2026